guide for patients
The patient guide aims to assist patients to determine if they are affected by the ASR recall and learn more about testing.
Patient information
DePuy has issued a voluntary recall of its ASR™ XL Acetabular Hip System and DePuy ASR™ Hip Resurfacing System.
Your patients will have questions, and our goal is to help you answer your patients’ questions and support their prompt follow up care and treatment.
Patients who had hip surgery prior to July 2003 are not subject to this recall.
call us for assistance
Should you have any outstanding questions please contact the ASR Help Line on 0800 2794865 or 01908 302 195. Lines are open from 09.00 – 17.00, Monday to Friday.
DePuy makes patient safety and health a top priority and is continually evaluating data about its products, including the ASR hip systems. Most ASR hip replacement surgeries have been successful.
In August 2010 DePuy recalled the ASR system having received new, at the time, unpublished 2010 data from the National Joint Registry (NJR) of England and Wales. The data shows the five year revision rate for the ASR™ Hip Resurfacing System is approximately 12 percent and for the ASR™ XL Acetabular System is approximately 13 percent. These revision rates are across the entire size range. The risk for revision was highest with ASR head sizes below 50 mm in diameter and among female patients.
Because the new NJR data shows a higher than expected revision rate at five years, DePuy issued a voluntary recall of all ASR products.
Country Region:
Do not include in the landing page